Author

E. Lugli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:flow cytometry· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Aghemo· 1 shared A. D. Macandog· 1 shared A. Lleo· 1 shared A. Termanini· 1 shared B. Franceschini· 1 shared C. B. Nava Lauson· 1 shared C. Catozzi· 1 shared C. Peano· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Aghemo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defineshyperactivated Tregs as a potential therapeutic target

G. Alvisi, A. Termanini, C. Soldani, F. Portale, R. Carriero, K. Pilipow, M. Polidoro, B. Franceschini, I. Malenica, S. Puccio, V. Lise, V. Zanon, F. S. Colombo, M. Tufano, C. Peano, , A. Lleo

This study identifies hyperactivated Tregs in iCCA as a therapeutic target through multimodal single-cell profiling of immune infiltrates.

bioRxiv · Mar 6, 2022Immunology

GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in early-stage colorectal tumors and predict poor clinical outcome.

S. Tiberti, C. Catozzi, C. Scirgolea, O. Croci, M. Ballerini, D. Cagnina, C. Soriani, A. D. Macandog, C. B. Nava Lauson, G. Bertalot, W. L. Petz, S. P. Ravenda, V. Licursi, P. Paci, M. Rasponi, , T. o. MANZO

The paper identifies GZMKhigh CD8+ T effector memory cells in early-stage CRC tumors, which correlate with neutrophil abundance and predict poor clinical outcomes.

bioRxiv · Dec 14, 2021Immunology